)
Microba Life Sciences (MAP) investor relations material
Microba Life Sciences Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved annualized run rate of 20,000 core tests globally, with strong growth in Australia and the UK, supporting the path to regional break-even by FY26 end.
Q1 FY26 core tests reached 4,931, up 145% year-on-year, with record MetaXplore sales in Australia and the UK.
Strategic discontinuation of legacy products, with legacy revenue replaced by growth product revenue; transition to focus on core Growth testing products is nearly complete.
Major brand consolidation and operational efficiency initiatives are scheduled for Q2 FY26 to unify global brands and enhance marketing efficiency.
Transitioned therapeutics from R&D to a partnering phase, with sector deal catalysts expected before end of CY2025.
Financial highlights
Q1 FY26 total revenue was $3.6m (AUD 3.6 million), down 1% year-on-year due to legacy product discontinuation; excluding legacy, revenue grew 42%.
Growth product revenue reached $1.9m, up 151% year-on-year; base product revenue was $1.3m, down 15% year-on-year.
Core testing product volumes up 145% year-on-year.
UK supplement sales were $1.0m, down 20% year-on-year, but Invivo branded supplements grew 7% year-on-year.
Cash and equivalents at 30 September 2025 totaled $13.89m.
Outlook and guidance
On track to achieve regional break-even in Australia and the UK by end of FY26, targeting over 24,000 core tests.
Already reached an annualized run rate of 20,000 tests, with growth expected to accelerate in the second half.
Q2 FY26 will mark the completion of the transition to core Growth products, with no legacy product revenue from Q3.
Entry into US and Europe planned, with initial market penetration in one geography per region.
No further R&D expenditure from FY26; focus shifts to partnering and deal-making in therapeutics.
Next Microba Life Sciences earnings date
Next Microba Life Sciences earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)